Promacta® Oral Suspension Recalled for Possible Peanut Contamination
Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site. Lesen Sie weiter auf: Promacta® Oral Suspension Recalled for Possible [...] .../Auszug
